Organoid Technology Comparison

Compare leading organoid platforms, biobanks, and service providers. Find the right partner for your 3D cell culture and patient-derived model needs.

← Back to Tools
Tissue Type
Source
HUB Organoids
Pioneer in patient-derived organoids
Patient-Derived GMP Available

Tissue Types

Intestine Liver Pancreas Kidney Breast Lung
Biobank Size 1,000+ models
Lead Time 2-4 weeks
Cost Range $$$
Regulatory Data ✓ Available
Crown Bioscience
World's largest tumor organoid collection
Patient-Derived CRO Services

Tissue Types

Tumor (30+ types) Liver Lung Colorectal
Biobank Size 3,000+ PDX/organoids
Lead Time 1-3 weeks
Cost Range $$-$$$
Genomic Data ✓ Characterized
StemCell Technologies
Complete iPSC-derived organoid toolkit
iPSC-Derived Kits & Reagents

Tissue Types

Intestine Brain Liver Cardiac Lung
Product Type Kits & Media
Lead Time 1-2 weeks (kits)
Cost Range $$
Protocol Support ✓ Extensive
DefiniGEN
Defined iPSC differentiation protocols
iPSC-Derived Disease Models

Tissue Types

Liver (Hepatocytes) Intestine Pancreas (Beta cells)
Specialty Metabolic diseases
Lead Time 2-6 weeks
Cost Range $$$
Custom Disease Models ✓ Available
InSphero
Scaffold-free 3D microtissue leader
iPSC & Primary HTS Ready

Tissue Types

Liver (3D InSight) Tumor Spheroids Pancreas (Islets) Cardiac
Format 96/384-well plates
Lead Time 1-2 weeks
Cost Range $$
Throughput High (HTS)
STEMCELL / Brain Organoids
Cerebral organoid specialists
iPSC-Derived Research Grade

Tissue Types

Cerebral Retinal Spinal Cortical
Maturation 30-90+ days
Lead Time 4-12 weeks
Cost Range $$$
Disease Modeling ✓ Neurodegeneration
ATCC
Trusted biological standards provider
Multiple Sources Authenticated

Tissue Types

Intestine Liver Lung Kidney
Product Type Authenticated lines
Lead Time 1-2 weeks
Cost Range $$
QC Standards ✓ ISO certified
Champions Oncology
TumorGraft organoid platform
Patient-Derived Preclinical CRO

Tissue Types

Solid Tumors Colorectal Ovarian Pancreatic
Biobank Size 1,500+ PDX models
Lead Time 2-4 weeks
Cost Range $$$
Clinical Correlation ✓ Available
Vendor ↕ Primary Tissues ↕ Source ↕ Biobank Size ↕ Lead Time ↕ GMP ↕ Cost ↕ Actions
HUB Organoids Netherlands
Intestine Liver +4 more
Patient 1,000+
2-4 weeks
 Yes
Crown Bioscience Global
Tumor Liver +2 more
Patient 3,000+
1-3 weeks
 CRO
StemCell Technologies Canada
Brain Intestine +3 more
iPSC Kits
1-2 weeks
 Kits Only
InSphero Switzerland
Liver Tumor +2 more
Both Ready-to-use
1-2 weeks
 Research
DefiniGEN UK
Liver Intestine Pancreas
iPSC Custom
2-6 weeks
 Yes

🧬 iPSC vs Patient-Derived

  • iPSC: Scalable, reproducible, isogenic controls available
  • Patient-Derived: Better disease relevance, clinical correlation
  • iPSC ideal for mechanism studies, screening
  • PDO best for personalized medicine, biomarkers
  • Consider hybrid approaches for validation

📋 Key Selection Criteria

  • Tissue type and disease model availability
  • Throughput requirements (HTS vs mechanistic)
  • Regulatory pathway needs (GLP, GMP)
  • Timeline and budget constraints
  • In-house capability vs outsourced services

🔬 Common Applications

  • Drug toxicity screening (hepatotoxicity, cardiotox)
  • Oncology drug response prediction
  • Disease modeling (IBD, diabetes, neurodegeneration)
  • Personalized medicine and companion diagnostics
  • ADME and drug metabolism studies

© 2025 Patient Analog. All rights reserved.

FDA Modernization Act 3.0 Educational Resource

© 2025 Patient Analog. All rights reserved.

Educational content created by J Radler for the biotech and scientific community. Last updated: February 4, 2026.

Free to share for educational purposes with attribution.